ADRA2A anticorps
Aperçu rapide pour ADRA2A anticorps (ABIN1731578)
Antigène
Voir toutes ADRA2A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Reacts with the C-terminus part of human ADRA2A
-
Réactivité croisée
- Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Cross reacts with mouse and rat protein.
-
Purification
- Antigen affinity purified
-
Immunogène
- Synthetic peptide from human Adrenergic Receptor alpha-2A.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: ELISA (1:20000), IF (1:100 - 1:500), IHC-P (10 μg/mL), WB (1:500 - 1:1000)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, NaCl 150 mM, glycerol 50 % , Sodium azide 0.02 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for up to one year.
-
-
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Autre désignation
- ADRA2A
-
UniProt
- P08913
-
Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
Antigène
-